Cilazapril
From Wikipedia, the free encyclopedia
|
Cilazapril
|
|
| Systematic (IUPAC) name | |
| (5S,8S)-5-{[(1S)-1-ethoxycarbonyl-3-phenyl-propyl] amino}-6-oxo-1,7-diazabicyclo[5.4.0]undecane-8- carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | C09 |
| PubChem | |
| Chemical data | |
| Formula | C22H33N3O6 |
| Mol. mass | 435.514 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Cilazapril is a pyridazine ACE inhibitor.
|
|||||||||||

